Significant Ownership of Patrick G. Enright
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Patrick G. Enright focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Menlo Park, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Patrick G. Enright with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Patrick G. Enright
Significant Ownership of Patrick G. Enright
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MANE | Veradermics, Incorporated | Common Stock, $0.00001 par value per share | 11% | $320,186,462 | 4,653,873 | 0% | Patrick G. Enright | 01 May 2026 | |
| CGON | CG Oncology, Inc. | Common Stock, $0.0001 par value per share | 6% | $121,032,477 | 4,662,268 | Patrick G. Enright | 11 Sep 2025 | ||
| ZBIO | ZENAS BIOPHARMA, INC. | Common Stock, $0.0001 par value per share | 4.9% | $58,425,578 | 2,631,522 | Patrick G. Enright | 09 Oct 2025 |
Schedules 13D/G Reported by Patrick G. Enright:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.